Federal Supply Schedule 36F79718D0528
Award Date 9/1/18
Last Date to Order 7/31/25
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Abbvie US LLC was awarded a $12.1 billion Federal Supply Schedule (FSS) contract by Veterans Integrated Service Network 12 for the provision of drugs, pharmaceuticals, and hematology-related products, effective July 1, 2025, through June 30, 2030. This multiple-award, non-set-aside contract serves as the master vehicle under which the Department of Veterans Affairs procures pharmaceutical products to support veteran healthcare delivery across its medical centers and integrated service...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Blanket Purchase Agreement (BPA) to AbbVie US LLC for the supply of pharmaceutical products, specifically DUOPA and VYALEV medications, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract carries a ceiling value of $15 million with an award date of August 1, 2025, and an ultimate completion date of July 31, 2026. This BPA was issued without a set-aside designation,...
- The Federal Supply Schedule contract award to Abbvie US LLC provides a $13.2 million ceiling for the procurement of medical equipment and supplies for the Department of Veterans Affairs (VA) and Indian Health Service (IHS). This multiple-award IDV has an ordering period through November 2029 and supports critical healthcare services for veterans and Native American populations. Abbvie US LLC, a subsidiary of the global biopharmaceutical company Abbvie Inc., has been awarded this FSS contract...
- This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $25,000.00 and...
- This federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs to Allergan USA Inc., a subsidiary of AbbVie Inc. The contract has a ceiling value of $4,040,000,000 and an ultimate completion date of July 31, 2025. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) to various federal agencies, primarily supporting reconstructive and aesthetic surgical procedures for military...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
- Pharmacyclics LLC, an AbbVie subsidiary, holds a multiple-award Federal Supply Schedule contract (FSS-61-IB) for the supply of pharmaceutical and hematology-related products under General Services Administration Schedule 65 I B. Awarded on November 1, 2017, with an ultimate completion date of February 28, 2026, this contract carries a ceiling value of $761,600,000 and serves the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. The...
- The U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule contract (FSS-61-IB) to UCB, Inc., a global biopharmaceutical company, for the procurement of pharmaceutical drugs and related products. The contract has a ceiling value of $625,636,910 and a period of performance through September 14, 2025. Under this contract, UCB, Inc. will supply a variety of pharmaceutical products to the VA, with a focus on drugs used to treat neurology and immunology disorders, such as...
- The Federal Supply Schedule (FSS) contract award is for DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS (65 I B) on behalf of the Veterans Integrated Service Network 12, a civilian federal agency. The $51,322,640.00 ceiling value contract was awarded on July 1, 2020 to Assertio Therapeutics Inc., a for-profit manufacturer, with a period of performance through October 14, 2025. This multiple award contract provides federal agencies access to a variety of pharmaceutical products and...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to EMD Serono Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $271,515,660.00. The period of performance runs from the award date of April 15, 2018 through April 14, 2025. The contract is intended to procure a wide range of pharmaceutical and hematology-related products for the Department of...
Name | Description | Awardee | Potential Value | AwardDate | LastDateToOrder | Updated At |
|---|---|---|---|---|---|---|
36F79718D0528-36E79723A0024 | Abbvie US LLC | $12.0m | 11/1/23 | 7/31/25 | 7/16/25 | |
36F79718D0528-36E79719A0003 | Abbvie US LLC | $8.5m | 11/1/18 | 10/31/23 | 12/16/22 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36F79718D0528-36C24920N0470 | Abbvie US LLC | $12.8k | 5/5/20 | 5/6/20 | 5/5/20 | |
Delivery Order 36F79718D0528-36C24920F0414 | Abbvie US LLC | $12.8k | 7/24/20 | 8/5/20 | 7/24/20 | |
Delivery Order 36F79718D0528-36C24919N0402 | Abbvie US LLC | $12.9k | 2/22/19 | 3/4/19 | 2/22/19 | |
Delivery Order 36F79718D0528-36C24921N0193 | Abbvie US LLC | $12.8k | 11/25/20 | 12/4/20 | 11/25/20 | |
Delivery Order 36F79718D0528-36C24920N0228 | Abbvie US LLC | $12.9k | 12/4/19 | 12/4/19 | 12/13/19 |